Skip to Content

New technology gives important knowledge of myeloproliferative neoplasms

At this year’s ASH Meeting, Shira Rosenberg shared the results of genotyping of transcriptomes of CALR-mutated essential thrombocythemia patients. The study revealed that interferon-alpha promotes early lymphoid development and, uniquely in CALR mutated cells myeloid differentiation, providing a novel mechanism of actions underlying the effects of interferon-alpha in patients with myeloproliferative neoplasms.

Shira Rosenberg

Lue artikkeli

Jos olet lääkäri, farmaseutti tai rajatun lääkkeenmääräämisoikeuden omaava sairaanhoitaja, pääset lukemaan artikkelin kirjautumalla käyttäjäksi BestPractice Nordic -sivustolle.

Back to top